N
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Price:
21
CNY
2.24%
Market Closed
Market Cap:
¥8.4B
Relative Value
The Relative Value of one Nanjing Vazyme Biotech Co Ltd stock under the Base Case scenario is 20.95 CNY. Compared to the current market price of 21 CNY, Nanjing Vazyme Biotech Co Ltd is Fairly Valued.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
20.95
CNY
Fairly Valued
N
Multiples Across Competitors
Competitors Multiples
Nanjing Vazyme Biotech Co Ltd Competitors
Nanjing Vazyme Biotech Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
N
|
Nanjing Vazyme Biotech Co Ltd
SSE:688105
|
8.4B CNY | 6.2 | -281.8 | -53.9 | -53.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.7B USD | 6.4 | 163.8 | 15.9 | 22.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.8B USD | 5.5 | 28.1 | 19.8 | 19.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD | 6.2 | 22.3 | 15.1 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.6B USD | 10.2 | 32.6 | 24 | 25 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.8B USD | 5.7 | 18.1 | 15.4 | 17.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.7B AUD | 3.9 | 20.3 | 13.6 | 16.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR | 14.5 | 34.2 | 58.4 | 60 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
